D-19466, a new cyclobutane-platinum complex with antitumor activity
- 1 September 1990
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 116 (5) , 439-442
- https://doi.org/10.1007/bf01612990
Abstract
D-19466, a new platinum complex, was characterized. It showed no nephrotoxic side-effects as determined by the measurement of blood urea. It was cytotoxic in vitro for tumor cells in concentrations comparable to or lower than cytotoxic concentrations of cisplatin. It had excellent anticancer activity in vivo against a number of murine experimental tumors, including a cisplatin-resistant P388 line. Clinical evaluation of this compound has therefore been initiated.Keywords
This publication has 4 references indexed in Scilit:
- THE TETRAZOLIUM DYE ASSAY FOR RAPID INVITRO ASSESSMENT OF CYTO-TOXICITY1989
- Carboplatin: current status and future prospectsCancer Treatment Reviews, 1988
- Iproplatin and carboplatin induced toxicities: Overview of phase II clinical trial conducted by the EORTC early clinical trials cooperative group (ECTG)European Journal of Cancer and Clinical Oncology, 1988
- Primary Bioassay of Human Myeloma Stem CellsJournal of Clinical Investigation, 1977